AU2003256532A1 - Methods and compositions concerning altered yellow fever virus strains - Google Patents

Methods and compositions concerning altered yellow fever virus strains

Info

Publication number: AU2003256532A1
Authority: AU; Australia
Prior art keywords: altered; methods; fever virus; yellow fever; virus strains
Prior art date: 2002-07-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003256532A

Other versions

AU2003256532A8 (en

Inventor

Alan Barrett

Monica Mcarthur

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Texas System

Original Assignee

University of Texas System

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-19

Filing date

2003-07-11

Publication date

2004-02-09

2003-07-11 Application filed by University of Texas System filed Critical University of Texas System

2004-02-09 Publication of AU2003256532A1 publication Critical patent/AU2003256532A1/en

2004-02-09 Publication of AU2003256532A8 publication Critical patent/AU2003256532A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU2003256532A 2002-07-19 2003-07-11 Methods and compositions concerning altered yellow fever virus strains Abandoned AU2003256532A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US39744002P	2002-07-19	2002-07-19
US60/397,440		2002-07-19
PCT/US2003/022001 WO2004009764A2 (en)	2002-07-19	2003-07-11	Methods and compositions concerning altered yellow fever virus strains

Publications (2)

Publication Number	Publication Date
AU2003256532A1 true AU2003256532A1 (en)	2004-02-09
AU2003256532A8 AU2003256532A8 (en)	2004-02-09

Family

ID=30771061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003256532A Abandoned AU2003256532A1 (en)	2002-07-19	2003-07-11	Methods and compositions concerning altered yellow fever virus strains

Country Status (3)

Country	Link
EP (1)	EP1546176A4 (en)
AU (1)	AU2003256532A1 (en)
WO (1)	WO2004009764A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2459709T3 (en)	2009-07-31	2014-12-01	Ge Healthcare Bio Sciences	HIGH-REPLACED YELLOW FEBER VIRUS TREASURY WITH INCREASED CELL STORAGE
AR079970A1 (en) *	2010-07-23	2012-02-29	Xcellerex Inc	HIGH PERFORMANCE VIRUSES OF THE YELLOW FEVER VIRUS WITH INCREASED PROPAGATION IN THE CELLS
CA2836501A1 (en) *	2011-07-12	2013-01-17	Gwong-Jen J. Chang	Identification of a west nile virus cd4 t cell epitope and use thereof
WO2013138670A1 (en) *	2012-03-15	2013-09-19	Icahn School Of Medicine At Mount Sinai	Yellow fever virus ns5 mutants as flavivirus vaccine candidates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL131600A0 (en) *	1997-02-28	2001-01-28	Ora Vax Inc	Chimeric flavivirus vaccines
BRPI9701774B8 (en) *	1997-04-11	2015-09-29	Fundação Oswaldo Cruz Fiocruz	mutant and infectious yellow fever virus cdna, DNA construct, recombinant yellow fever virus and human vaccine against yellow fever infections.

2003
- 2003-07-11 AU AU2003256532A patent/AU2003256532A1/en not_active Abandoned
- 2003-07-11 EP EP03765574A patent/EP1546176A4/en not_active Withdrawn
- 2003-07-11 WO PCT/US2003/022001 patent/WO2004009764A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2003256532A8 (en)	2004-02-09
WO2004009764A2 (en)	2004-01-29
EP1546176A4 (en)	2006-01-11
EP1546176A2 (en)	2005-06-29
WO2004009764A3 (en)	2004-04-22

Similar Documents

Publication	Publication Date	Title
EP2366803B8 (en)	2015-08-19	Compositions and methods for detecting west nile virus
AU2002357119A1 (en)	2003-06-30	Mitocidal compositions and methods
AU2003262747A1 (en)	2004-03-11	Compounds, compositions, and methods
AU2003236527A1 (en)	2003-12-31	Compounds, compositions, and methods
AU2003270015A1 (en)	2003-12-02	Compounds, compositions, and methods
AU2002254343A1 (en)	2002-10-08	Halo-polymer nanocomposite compositions, methods, and products employing such compositions
AU2003295511A1 (en)	2004-06-03	Methods and compositions for diagnosing dysplasia
EP1578940A3 (en)	2005-09-22	Methods and compositions for diagnosing dysplasia
AU2003221683A1 (en)	2004-01-06	Thermal interface materials and methods for their preparation and use
AU2003299612A1 (en)	2004-07-09	Compounds, compositions and methods
AU2003270605A1 (en)	2004-04-30	Compositions for thermal insulation and methods of using the same
AU2003239614A1 (en)	2003-12-12	Cardiolipin compositions, methods of preparation and use
AU2003274211A1 (en)	2004-02-25	Flame-retardant composition, preparation method and use thereof
AU2003256805A1 (en)	2004-02-09	Compounds compositions and methods
AU2003270779A1 (en)	2004-04-08	Vaccine compositions and adjuvant
AU2002231961A1 (en)	2002-08-28	Detectable compositions, methods of forming the same and detection techniques
AU2003266815A1 (en)	2004-04-19	Immunoglobulin compositions and methods
AU2003286486A1 (en)	2004-05-04	Methods and compositions for immunization against hiv
AU2002307971A1 (en)	2003-04-10	Vaccine against the nile fever virus
AU2002357748A1 (en)	2003-06-10	Osteopontin-related compositions and methods
WO2005110009A8 (en)	2008-05-22	COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
AU2002360547A1 (en)	2003-07-24	Monoterpene compositions and uses thereof
AU2003297079A1 (en)	2004-07-29	Anti-filming materials, compositions and methods
AU2003277079A1 (en)	2004-05-04	Compounds, compositions, and methods
AU2002345878A1 (en)	2003-01-08	Ilt3 and ilt4-related compositions and methods

Legal Events

Date	Code	Title	Description
2005-05-12	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase